Cookie Notice

Last Updated: November 27, 2024

 

Privacy Notices

Galleri image employer

Cookie Notice

This Cookie Notice describes how GRAIL, Inc. (“GRAIL,” “we,” “us,” or “our”) uses cookies and similar technologies on one or more of our websites at which this Cookie Notice is posted including, GRAIL.com (the “GRAIL Site”), Galleri.com (the “Galleri Site”), provider.grail.com (the “Provider Portal) and my grail.com (the “Patient Portal”) (collectively, our “Sites”). This Cookie Notice supplements and should be read in connection with our Privacy Notice.

What are Cookies?

A cookie is a small text file that is placed on your hard disk by a web page server. Cookies contain information that can later be read by a web server in the domain that issued the cookie to you. There are other technologies that are similar to cookies, such as web beacons and pixels. These technologies function like cookies, and we refer to cookies and these similar technologies collectively as cookies for the purposes of this Cookie Notice. You can learn more information about cookies at https://allaboutcookies.org/

Your Choices

You have the ability to accept or decline cookies. Many web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer. If you choose to decline cookies, you may not be able to sign in or use other interactive features of our Sites that depend on cookies. You can manage your cookie preferences on our Sites at any time by visiting our Cookie Choices banner (click on "Cookie Notice and Choices" in the site footer).  

Questions

Have questions or concerns about our Cookie Notice? Contact us at privacy@grailbio.com

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.